Major news for anyone following cancer treatments: Citius Oncology just launched Lymphir, a new immunotherapy for adults with relapsed or stubborn cutaneous T-cell lymphoma (CTCL). This skin cancer can be super tough to treat, but Lymphir is designed to target cancer cells and help clear those painful, itchy lesions. The FDA just gave it the green light, and the company’s stock shot up almost 14%! Big moment for cancer care! #Health #BodyHealth #CancerTreatment